BackMedigus Ltd. - Warrants Overview

Medigus Ltd. - Warrants Total Liabilities

Track Medigus Ltd. - Warrants's total liabilities ($31M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$31.46M
26.77% YoYΔ $-11.50M vs prior year quarter

Peer trimmed avg / median

Loading

Medigus Ltd. - Warrants Total Liabilities History

Loading

Medigus Ltd. - Warrants vs. peers: Total Liabilities Comparison

Loading

Medigus Ltd. - Warrants Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Medigus Ltd. - Warrants (MDGSW) FAQ

As of the most recent data (December 2023), MDGSW shows a total liabilities of $31M. That compares with $43M in the prior-year period — down 26.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MDGSW's total liabilities is now $31M (was $43M) — a 26.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Medigus Ltd. - Warrants is outperforming or lagging.

Tracking MDGSW's total liabilities over time shows whether Medigus Ltd. - Warrants is scaling, shrinking, or reshaping that part of the business. The current reading is $31M That compares with $43M in the prior-year period — down 26.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Medigus Ltd. - Warrants's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $31M) with ownership activity and broader fundamentals.

Medigus Ltd. - Warrants's total liabilities is $31M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.